Lannett's Posaconazole Deal With A Highly Credible Partner Definitively Averts Bankruptcy ConcernsSeeking Alpha • 09/04/19
Lannett stock soars 34% on news to be exclusive distributor of Posaconazole delayed-release tablets in the U.S.Market Watch • 08/28/19
Lannett Company, Inc. (LCI) CEO Timothy Crew on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/28/19
Lannett stock up 40% with no news released; short interest stands at 74% of floatMarket Watch • 07/22/19